Monday, September 14, 2026

Vozinha’s Stunning Rise: From World Cup Hero to Colo-Colo Star in 2026

Goalkeeper Vozinha joins Colo-Colo after a stellar World Cup, propelling Cape Verde to the Round of 32 and gaining massive popularity.

Botox, Fillers, and Bone Surgery? The Surprising Ways People Are Chasing the Perfect V-Line

A well-defined jawline is key for a beautiful face, with many preferring a V-line for a smaller, more dimensional appearance.

Can Messi Break the World Cup Scoring Record? Key Stats Ahead of Argentina vs. Egypt Showdown

Messi leads Argentina in pursuit of back-to-back World Cup titles, aiming to extend his record-breaking goal streak against Egypt.

Tag: immunotherapy

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Revolutionary In Situ Cancer Vaccines: Can They Cure Relapsed and Metastatic Cancer?

Inha University reveals a next-gen immunotherapy strategy using tumors from patients to treat relapsed and metastatic cancers.

Unlocking Precision Medicine: New Antibody Design Targets KRAS(G12D) in Cancer Cells

Researchers at KAIST developed an antibody targeting KRAS(G12D) mutation, revolutionizing cancer treatment with precise immunotherapy.

Unlocking the Mystery: How Anti-CTLA-4 Boosts B Cell Response Against Brain Tumors

Researchers reveal that B cells, not just T cells, are crucial for the success of immune checkpoint inhibitors in treating glioblastoma.

Penetrium: The Next Breakthrough in Cancer Immunotherapy Starting Phase 2 Trials in the U.S.

Penetrium BioScience launches a Phase 2 clinical trial for Penetrium, targeting tumor microenvironments to enhance cancer immunotherapy.

Unlocking Cancer Treatment: Samsung Bioepis Achieves Keytruda Biosimilar Equivalence in Global Trials

Samsung Bioepis' biosimilar SB27 shows equivalence to Keytruda in key clinical trials, enhancing access to cancer immunotherapy.

Revolutionary Discovery: How Environmental Stress Affects Cold Tumors and NK Cell Function

A study reveals cold tumors' causes extend beyond genetics to include environmental stress and lifestyle, impacting immune response.

Daewoong Pharmaceutical Expands Biosimilar Push With Dupixent Copy Deal and Global CDMO Partnership

Daewoong Pharmaceutical partners with Chime Biologics to develop a Dupixent biosimilar, enhancing its global biosimilar business expansion.

Lunit to Present Five AI Biomarker Studies at ASCO 2026 Highlighting Expanded Clinical Applications

Lunit will present five AI studies at ASCO 2026, showcasing biomarker analysis for cancer treatment and patient response prediction.

How Dong-A ST’s SC5024 and ADC Innovations Could Change the Game Cancer Pipeline

Dong-A ST showcased its innovative cancer pipeline at AACR 2026, featuring promising preclinical findings and advanced therapeutic strategies.

Lunit’s AI-based bile duct cancer study selected for rapid oral presentation at U.S. oncology conference

Lunit will present five research abstracts at ASCO 2026, showcasing the expanding role of AI biomarkers in cancer treatment.

AACR 2026: How Korean Biotech Firms Are Leading the Charge in Cancer Research

AACR 2026 in San Diego will showcase South Korea's cancer tech innovations, featuring firms like Hanmi and Samsung Biologics.

Revolutionary Immune Therapy for Colon Cancer: How MAFB Protein Manipulation Enhances Treatment Response

Korea University researchers have developed a new colorectal cancer treatment strategy by regulating tumor-associated macrophages to enhance immune response.

How Hanmi’s Dual Inhibitor HM97662 is Revolutionizing Cancer Treatment: Key Insights from AACR 2026

Hanmi Pharmaceutical to present nine groundbreaking cancer research studies at AACR 2026, showcasing innovative therapies and AI-driven analytics.

Unlocking the Future of Cancer Treatment: UCI-101 CAR-NK Therapy by UCI Therapeutics

Matica BioLabs partners with UC Therapeutics to manufacture CAR-NK cell therapy, enhancing cancer treatment through dual-targeting technology.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.